Blockchain is primarily discussed in the context of financial markets disruption, but a US law could help it become an indispensable solution for the pharmaceutical industry as well, Bloomberg reports. The Drug Supply Chain Security Act from 2013 obliges drug makers and supply chain providers to improve tracking methods to prevent the spread of counterfeit medicines and speed up drug recalls.
Within less than two years, hospitals and pharmacies will be required to check whether the medicines they distribute originate from drug makers or repackagers. Currently, big pharma companies are thinking about ways of complying with the law, but healthcare analysts have already found the answer – blockchain. The distributed ledger technology (DLT), an umbrella term that encompasses blockchain, ...
This article appeared first on Cryptovest